Shares of Sun Pharma will be in focus after the company said its subsidiaries, SPII and Taro, have agreed to pay $200 million to settle an ...

Taro has paid around $99.3 million after taking into account working capital adjustments.

The approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Nystatin and Triamcinolone...

Under the terms of the settlement agreements, the subsidiaries will make an aggregate payment amounting to a combined total of USD 85 milli...

The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used p...

Under a deferred prosecution agreement reached with the DOJ, it said, adding that the dept will file an information for conduct that took p...

Quoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million...

Desoximetasone Topical spray, used for treatment of plaque psoriasis, has received approval from the US health regulator for sale in the Am...

Dr Reddy's Laboratories' shares today were trading at Rs 3,178.70 in the morning trade on the BSE, down 0.03 per cent.

The therapeutic 2-step Kamedis Bio-Herbal Dandruff Care System is used for treating itching and flaking associated with dandruff and seborr...

“In Sun-Taro’s case, they pushed up the price because there was not much competition or suppliers.”

Suven Life Sciences said it has given exclusive license to Taro Pharmaceutical Industries to market its Malathion Lotion.

The Desoximetasone Ointment USP is the generic version of Taro Pharmaceuticals USA Inc's Topicort and shipping will commence immediately, G...

Glenmark Pharmaceuticals on Thursday said it has signed a licence and supply agreement with Israeli firm Taro Pharmaceuticals to sell a bra...

Pharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...

Prodded by the Reserve Bank of India, the Tayals, who control Bank of Rajasthan, have begun talks with large private sector banks for a pos...

Second-largest overseas buyout by an Indian pharma company will give Sun an edge in North America where Israeli generics player records 90%...